Left Bundle Branch Block Predicts Better Survival in Women Than Men Receiving Cardiac Resynchronization Therapy
- 1 June 2013
- journal article
- research article
- Published by Elsevier in JACC: Heart Failure
- Vol. 1 (3) , 237-244
Abstract
No abstract availableKeywords
Funding Information
- Centers for Medicare & Medicaid Services/U.S. Food and Drug Administration (FDA) SafeRx Project and the FDA Office of Women's Health
This publication has 27 references indexed in Scilit:
- Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart FailureCirculation, 2012
- Meta-analysis: Cardiac Resynchronization Therapy for Patients With Less Symptomatic Heart FailureAnnals of Internal Medicine, 2011
- Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)Circulation, 2011
- Defining Left Bundle Branch Block in the Era of Cardiac Resynchronization TherapyThe American Journal of Cardiology, 2011
- Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart FailureNew England Journal of Medicine, 2010
- Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare PatientsCirculation, 2010
- Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure EventsNew England Journal of Medicine, 2009
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart FailureAnnals of Internal Medicine, 2004
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004